877-381-4200
Stem cell therapy is legal in the US.
What’s illegal is marketing specific unapproved stem cell products outside of clinical trials.
The confusion comes from FDA warning letters, medical tourism ads, and old arguments about embryonic research blending together with today’s rules.
This post breaks down exactly where the myth comes from and what the FDA, and states like Florida, actually allow.
If you’ve spent any time researching regenerative medicine, you’ve probably run into someone claiming stem cell therapy is illegal in the United States.
Maybe a friend said it, a clinic overseas implied it in an ad, or you saw a news story about a stem cell business getting shut down.
It’s an easy story to believe, but it isn’t true.
Stem cell therapy is legal in the US.
What confuses people is a patchwork of federal rules, state laws, and marketing claims that don’t always line up.
This guide walks through exactly why the myth exists and what the rules actually say.
SEE IF STEM CELL THERAPY IS RIGHT FOR YOU
Is Stem Cell Therapy Actually Illegal in the US?
No, stem cell therapy is not illegal in the United States.
The FDA allows certain stem cell treatments, especially those using a patient’s own cells for their original purpose, while restricting the sale of specific unapproved products outside of clinical trials.
The confusion comes from mixing up “not FDA approved” with “against the law.”
The Food and Drug Administration treats stem cells the way it treats most medical products: some need full approval, and some don’t.
Right now, the FDA has only licensed one broad category of stem cell product for general use, cord blood stem cells for treating certain blood disorders.
That’s a narrow category, but it doesn’t mean everything else is banned.
What’s actually illegal is selling or marketing a stem cell product that requires FDA approval and doesn’t have it, especially outside of a registered clinical trial.
Clinics that do this are breaking the law.
Clinics that use a patient’s own minimally processed cells for roughly the same function those cells already serve in the body are usually operating under a different, lighter set of rules.
Where the “It’s Illegal” Myth Actually Comes From
The myth doesn’t come from nowhere.
It usually grows out of four things getting blended together.
Confusing “Not FDA-Approved” With “Illegal”
Most people hear “not FDA approved” and assume it means banned.
In medicine, those are two different categories.
A treatment can be legal to offer and still not carry full FDA approval, especially when it uses a patient’s own cells in a minimally processed way.
The distinction comes down to how a product is classified, which shapes how it gets regulated later in this post.
News Coverage of Warning Letters and Clinic Shutdowns
The FDA has been increasingly active in this space.
Between 2016 and 2021, the number of US clinics selling stem cell products grew nearly five-fold, from 570 to 2,754, and that growth pulled more regulatory attention with it.
In late 2024, a California court ruling cracked down on clinics selling unproven stem cell therapies, and the FDA has continued sending warning letters to individual companies since.
Every one of these stories is accurate on its own.
Strung together in headlines, they create the impression that the entire field is illegal, when really it’s a specific group of noncompliant businesses getting flagged.
Mixing Up Adult Stem Cells With the Old Embryonic Stem Cell Debate
Stem cell therapy used in orthopedic and pain clinics today almost always comes from a patient’s own bone marrow or fat tissue, not embryos.
But the phrase “stem cell research” still carries baggage from the early 2000s, when embryonic stem cell research was genuinely restricted and politically controversial in the US.
That older debate lingers in public memory as part of the broader stem cell research conversation, even though the therapies offered in clinics today use a completely different, non-embryonic source of cells.
Medical Tourism Marketing That Implies the US Has Banned It
Some international clinics market themselves by implying, directly or indirectly, that patients have to travel abroad because stem cell therapy isn’t available at home.
That’s a sales pitch, not a fact.
It plays up the real risks of traveling for treatment, including inconsistent oversight and limited recourse if something goes wrong, while leaving out that similar or better-regulated options often exist closer to home in states like Florida.
What Does the FDA Actually Regulate?
The FDA regulates stem cell products based on how much they’re processed and what they’re used for, not simply the fact that they’re stem cells.
Products that are minimally manipulated and used for the same basic function they serve naturally face lighter oversight.
Products that are more heavily processed or used differently need full approval, similar to a new drug.
This distinction, often called 351 versus 361, comes from the Public Health Service Act. A 361 product typically means cells taken from a patient and given back to that same patient in roughly the same form, using a patient’s own cells rather than lab-expanded cells from an outside donor.
A 351 product usually involves cells that are expanded in a lab, combined with other substances, or used for a different purpose than their original one, and those need to go through the same clinical trial process as a new medication.
Because this distinction determines what a clinic can legally offer, it’s worth understanding the fuller FDA regulatory picture across different states before choosing where to get treatment.
Why Isn’t All Stem Cell Therapy “FDA Approved”?
Most stem cell therapies used for orthopedic and pain conditions aren’t “FDA approved” in the same sense as a new drug, because they don’t need to be.
Only products classified as 351, meaning they’re more heavily processed or used for a new purpose, go through the multi-year clinical trial process that ends in formal approval.
Full FDA approval is an expensive, multi-year process built for new drugs and heavily engineered biologics.
Applying that same pathway to every use of a patient’s own basic tissue would slow down safe, lower-risk treatments without adding much real protection, which is part of the reasoning researchers have pointed to when examining how the FDA regulates stem cell therapies.
It isn’t that regulators overlooked stem cells.
It’s that not every stem cell use fits the same risk category as a new pharmaceutical.
How Florida’s New Stem Cell Law Adds to the Confusion
State law adds another layer to an already complicated picture.
Florida’s SB 1768, effective July 1, 2025, lets specific licensed physicians offer certain stem cell therapies for orthopedic conditions, wound care, and pain management, even when those therapies don’t carry full FDA approval, as long as patients receive informed consent explaining that the treatment isn’t FDA approved.
That’s a meaningful shift for patients in Spring Hill and across Florida.
It gives physicians a clearer legal framework for offering these treatments locally, instead of patients assuming they’d need to travel out of state or out of the country to find anything similar.
It doesn’t mean anything goes, though.
Physicians still have to follow the law’s informed consent and licensing requirements, and the underlying FDA rules on which products can be marketed still apply.
How to Tell a Legitimate Clinic From an Unregulated One
A legitimate clinic explains clearly whether your treatment uses your own cells or a processed product, discloses which FDA category it falls under, and never guarantees a cure.
Red flags include vague claims about treating unrelated conditions, pressure to pay upfront in cash, and no mention of FDA status at all.
- The clinic can explain whether it’s using your own cells or a lab-processed product, and which FDA category applies.
- Claims are limited to conditions with real supporting evidence, not a long list of unrelated diseases.
- You’re given time to ask questions and receive written informed consent, not rushed into paying before you leave.
- The clinic is upfront about the real downsides and limitations of stem cell therapy, not just the benefits.
- Staff can answer direct questions about FDA compliance without redirecting or dismissing the question.
Taking time to properly vet a stem cell therapy clinic before you commit is one of the best ways to avoid the unregulated end of this industry, which is also the part that gives the whole field its illegal reputation in the first place.
How Orthobiologics Associates Approaches Regenerative Medicine
Orthobiologics Associates focuses on regenerative options for patients who want to avoid surgery when possible.
That includes orthobiologic treatments built around a patient’s own biology rather than heavily processed lab products, aimed at joint, spine, and soft tissue conditions.
Our cell therapy program is built around this same principle: using a patient’s own tissue in ways consistent with current FDA guidance, with a full explanation of what’s being offered and why, rather than vague promises.
We would rather a patient understand exactly what category their treatment falls into than sign up for something they don’t fully understand.
Stem cell therapy isn’t illegal in the US. It’s regulated, sometimes unevenly, and that gap between “regulated” and “banned” is where most of the confusion starts.
If you’re weighing your options and want a clear answer about what’s actually appropriate for your condition, Orthobiologics Associates can walk you through it.
FAQs
Is stem cell therapy legal in the United States?
Yes. Stem cell therapy is legal in the US, though it’s regulated differently depending on how the cells are processed and used. Treatments using a patient’s own minimally processed cells generally face lighter FDA oversight, while more heavily processed products need full approval through clinical trials.
Why isn’t stem cell therapy FDA approved for most conditions?
Most stem cell treatments for orthopedic and pain conditions don’t need full FDA approval because they fall into a lighter regulatory category reserved for minimally processed products used for their original function. Full approval is required only for more heavily processed or differently used products.
What’s the difference between a 351 and 361 stem cell product?
A 361 product usually involves a patient’s own cells, minimally processed and used for the same basic function they already serve in the body. A 351 product is more heavily processed, combined with other substances, or used for a new purpose, which means it has to go through the same approval process as a new drug.
How can I tell if a stem cell clinic is legitimate?
A legitimate clinic will clearly explain whether it uses your own cells or a lab-processed product, disclose its FDA classification, avoid guaranteeing cures, and give you written informed consent before treatment. Vague claims and pressure to pay immediately are warning signs.
Is stem cell therapy the same as embryonic stem cell research?
No. Most stem cell therapy offered in orthopedic and pain clinics today uses adult stem cells from a patient’s own bone marrow or fat tissue, not embryonic cells. The stricter legal debates from the early 2000s were specifically about embryonic stem cell research, which is separate from the adult cell treatments used in regenerative medicine today.
Recent Comments